Epidermal growth factor: A potent vasoconstrictor in experimental hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 3 45-3, 1999, Pages

  Florian, Jennifer A ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Contraction; Deoxycorticosterone acetate salt hypertension; Mitogen activated protein kinase kinase; Tyrosine kinases; Vascular smooth muscle

Indexed keywords

DEOXYCORTICOSTERONE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM TRANSPORT; CELL PROLIFERATION; CHANNEL GATING; GROWTH REGULATION; HYPERTENSION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0032896273     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.3.h976     Document Type: Article

References (32)

1. Adam, L. P., J. R. Haeberle, and D. R. Hathaway. Phosphorylation of caldesmon in arterial smooth muscle. J. Biol. Chem. 264: 7698-7703, 1989.
2. Bagby, S. P., E. Z. Kirk, L. H. Mitchell, M. M. O'Reilly, W. E. Holden, P. E. Stenberg, and A. C. Bakke. Proliferate synergy of ANG II and EGF in porcine aortic vascular smooth muscle cells. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F239-F249, 1993.
3. Berk, B. C., T. A. Brock, R. C. Webb, M. B. Taubman, W. J. Atkinson, M. A. Gimbrone, and R. W. Alexander. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J. Clin. Invest. 75: 1083-1086, 1985.
4. Buchdunger, E., U. Trinks, H. Mett, U. Regenass, M. Muller, T. Meyer, E. McGlynn, L. A. Pinna, P. Traxler, and N. B. Lydon. 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc. Natl. Acad. Sci. USA 91: 2334-2338, 1994.
5. Bukoski, R. D., P. DeWan, and J. Bo. Mechanism of the enhanced epidermal growth factor-induced growth response of genetically hypertensive vascular myocytes. Circ. Res. 69: 757-764, 1991.
6. Childs, T. J., M. H. Watson, J. S. Sanghera, D. L. Campbell, S. L. Pelech, and A. S. Mak. Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells. J. Biol. Chem. 267: 22853-22859, 1992.
7. Clegg, K. B., and M. P. Sambhi. Inhibition of epidermal growth factor-mediated DNA synthesis by a specific tyrosine kinase inhibitor in vascular smooth muscle cells of the spontaneously hypertensive rat. J. Hypertens. 7: S144-S145, 1989.
8. Jin, N., R. A. Siddiqui, D. English, and R. A. Rhoades. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1348-H1355, 1996.
9. Karpova, A. Y., M. K. Abe, J. Li, P. T. Liu, J. M. Rhee, W.-L. Kuo, and M. B. Hershenson. MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L558-L565, 1997.
10. Katoch, S. S., and R. S. Moreland. Agonist and membrane depolarization induced activation of MAP kinase in swine carotid artery. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H222-H229, 1995.
11. Kelleher, M. D., M. K. Abe, T.-S. O. Chao, M. Jain, J. M. Green, J. Solway, M. R. Rosner, and M. B. Hershenson. Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L894-L901, 1995.
12. Khalil, R. A., C. B. Menice, C.-L. A. Wang, and K. G. Morgan. Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ. Res. 76: 1101-1108, 1995.
13. Korsgaard, N., and M. J. Mulvany. Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats. Hypertension 12: 162-167, 1988.
14. Mangiarua, E., N. Basso, P. Ruiz, and A. C. Taquini. Vascular structural changes in DOC-salt hypertensive rats. Hypertension 3: S183-S186, 1981.
15. Merkel, L. A., L. M. Rivera, D. J. Colussi, and M. H. Perrone. Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864. Biochem. Biophys. Res. Commun. 192: 1319-1326, 1993.
16. Mokashi, S., D. L. Severson, and M. D. Hollenberg. Synergistic actions of epidermal growth factor-urogastrone and vasopressin in cultured aortic A-10 smooth muscle cells. J. Cell. Physiol. 152: 372-381, 1992.
17. Muramatsu, I., M. D. Hollenberg, and K. Lederis. Vascular actions of epidermal growth factor-urogastrone: possible relationship to prostaglandin production. Can. J. Physiol. Pharmacol. 63: 994-999, 1985.
18. 2+-ATPase activity by caldesmon. J. Biol. Chem. 259: 13656-13659, 1984.
19. Oka, Y., and D. N. Orth. Human plasma epidermal growth factor-β-urogastrone is associated with blood platelets. J. Clin. Invest. 72: 249-259, 1983.
20. Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670-674, 1991.
21. Saltis, J., A. Agrotis, and A. Bobik. Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent. J. Hypertens. 11: 629-637, 1993.
22. Saltis, J., A. C. Thomas, A. Agrotis, J. H. Campbell, G. R. Campbell, and A. Bobik. Expression of growth factor receptors on arterial smooth muscle cells. Dependency on cell phenotype and serum factors. Atherosclerosis 118: 77-87, 1995.
23. Sauro, M. D., and B. Thomas. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s). J. Pharmacol. Exp. Ther. 267: 1119-1125, 1993.
24. Sauro, M. D., and B. Thomas. Decreased sensitivity of aorta from hypertensive rats to vasorelaxation by tyrphostin. Life Sci. 53: 371-376, 1993.
25. Suithichaiyakul, T., K. B. Clegg, and M. P. Sambhi. Selectively enhanced stimulation of DNA synthesis by EGF in vascular smooth muscle cells from young and adult SHR. Clin. Exp. Hypertens. A12: 307-316, 1990.
26. Swaminathan, N., M. Vincent, J. Sassard, and M. P. Sambhi. Elevated epidermal growth factor receptor levels in hypertensive Lyon rat kidney and aorta. Clin. Exp. Pharmacol. Physiol. 23: 793-796, 1996.
27. Watts, S. W. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. J. Pharmacol. Exp. Ther. 279: 1541-1550, 1996.
28. Watts, S. W., K. M. Finta, M. C. Lloyd, D. S. Storm, and R. C. Webb. Enhanced vascular responsiveness to Bay K 8644 in mineralocorticoid- and N-nitro arginine-induced hypertension. Blood Press. 3: 340-348, 1994.
29. Wijetunge, S., and A. D. Hughes. Effect of platelet-derived growth factor on voltage-operated calcium channels in rabbit isolated ear artery cells. Br. J. Pharmacol. 115: 534-538, 1995.
30. Xu, Q., Y. Liu, M. Gorospe, R. Udelsman, and N. J. Holbrook. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J. Clin. Invest. 97: 508-514, 1996.
31. Zheng, C.-F., and K.-L. Guan. Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J. 13: 1123-1131, 1994.
32. Zheng, X.-L., S. Mokashi, and M. D. Hollenberg. Contractile action of ethanol in guinea pig gastric smooth muscle: inhibition by tyrosine kinase inhibitors and comparison with the contractile action of epidermal growth factor-urogastrone. J. Pharmacol. Exp. Ther. 282: 485-495, 1997.